Microbix Biosystems has attained medical devices establishment licensing from Health Canada, allowing the immediate use of its quality assessment products (QAPs™) by clinical laboratories across the country, including its QAPs to help ensure the accuracy of COVID-19 disease testing.
Microbix Biosystems Attains Health Canada Establishment Licensing
Previous
Previous
Perimeter Medical Imaging Receives $10.4 Million Grant
Next
Next